Request Speaker Information
Our Commitment to Your Safety
We have experienced the enthusiasm of returning to live in-person events this year, having safely and successfully hosted more than 10,000 executives to date. While we are thrilled to convene together to propel growth within CRE, COVID-19 remains a worldwide concern and Bisnow is committed to practicing safe protocols at our events. You can expect the following:
Proof of vaccination or a negative Covid-test result from the past 72 hours will be required as a condition of entry to this event. Proof of vaccination or negative test results can be shown via a physical card or a digital image of your records.
In accordance with CDC guidelines, we are recommending that all participants wear a mask, regardless of vaccination status. Masks will be made available at the door.
Temperature checks will be conducted at entry.
Attendance at the event will be capped and no tickets will be sold at the door.
Contact tracing procedures will be employed for any reported exposure.
Socially distanced seating will be available in the main event space.
Enhanced sanitization protocols will be adhered to throughout the event space including regularly disinfecting surfaces throughout the event and hand sanitizer provided to all attendees.
As local regulations and guidance evolve, the CRE industry continues to lead the way forward. We look forward to gathering safely to do what we do best: network, connect, and engage to do more business. We look forward to hosting you soon.
Speakers and Panels
Greater Boston Expansion & Footprint
Race for New Facilities
Kenn Turner
President, CEO
Massachusetts Life Sciences Center
Douglass Cuff
SVP of Real Estate
IQHQ
Rob Dickey
Executive Vice President
Leggat McCall
Steven Kelly
CEO
Timberline Construction
John Sullivan
President of Architecture, Partner
SGA
Martin Togni
Partner
Allen Matkins
Designing Facilities for Growth & Customization
Balancing Flexibility and Custom Build Out
Duncan Gilkey
SVP Asset Management & Director of Leasing
The Davis Companies
Amrit Chaudhuri
CEO
SmartLabs
Matt Haverty
VP, Head of Construction
Oxford Properties
Edwin Hargrave
Associate Principal, Director of Integrated Design
TRIA
Anthony Montalto
Partner
Jaros Baum & Bolles (JB&B)
Lauren Laidlaw
Vice President, Sales and Marketing
Safety Partners
Understanding the Tenant Experience: Difference between BioTech & Pharma
The Left and Right Hand of Life Sciences
Joe Breen
Project Executive
Lee Kennedy Company
Nick Trocki
Vice President
Jumbo Capital
RJ Panzo
Senior Director
Breakthrough Properties
Thomas Joyner
Partner
AHA Consulting Engineers
Biotech Trends: Future of GMP Facilities
Finding Value in an Expensive Undertaking
Tyler McGrail
Senior Managing Director
Newmark
Denis Desmond
Head of Real Estate & Facilities
Crispr Therapeutics
Bill Hunter
Managing Director
Perceptive Real Estate Equities, Inc.
Ray Doyle
Managing Principal
WB Engineers + Consultants
Geoff Kramer
Life Science Project Development
Consigli Construction
Growth Opportunities for Boston's Newest Players
Capitalizing on Boston's Hottest Asset Class
Gary Kerr
Senior Managing Director
Greystar
Marci Griffith Loeber
Managing Principal
Griffith Properties
Tucker Kelton
Founder, Managing Partner
Camber Development
Jillian McLaughlin
SVP of Corporate Strategy & Development, Head of RE
SmartLabs
Why This Matters
What you'll learn:
What is driving the location of biotech developments and which projects are dictating market trends and rates?
How do developers and builders strike a design balance between flexible space to allow for growth but also specific enough to create customized value for tenants? How does this impact lease length negotiations?
What specific design elements are in high demand specific for biotech facilities, including research and development, wet lab, computational and office space?
How will the increase in Good Manufacturing Practice (GMP) facilities impact the development locations and future life science trends?
What is the difference between biotech and pharmaceutical facilities? How does the lab type determine leverage between owner and tenant when negotiating lease length, building amenities and layout?
How you'll do more business: As we navigate an increasingly competitive Boston Life Sciences Market with more demand than space, gain exclusive insights into where to find and create value in the biotech space outside of the traditional Cambridge hub. We will examine the development pipeline, the difference between biotech and pharmaceutical spaces, what the recent emphasis to GMP facilities means and the latest trends in building design.
Who attends: Owners, Developers, Tenants, Brokers, life science professionals, lawyers, designers, architects, engineers and general contractors.
Why should you attend: Bisnow events bring together the biggest power players in the industry to identify opportunities, build your network, and expand your business. With the largest audience of commercial real estate professionals in the world, and a very informed life sciences community, there is no better way to network and strengthen your business.
For questions, recommendations, comments, or press inquiries please email our Boston Event Producer, Chris Picher at chris.picher@bisnow.com.
Venue
Boston Park Plaza
50 Park Plaza
Boston, MA 02116
Ballroom: Georgian Ballroom (Mezzanine Level)
Parking information: Valet Parking is $30 (available at 34 Columbus Ave)
Agenda
| Time | Activity |
|---|---|
|
11:30 AM
12:30 PM
|
Pre-Event Networking
Kick off the morning by networking with the biggest players at the intersection of life sciences and commercial real estate. |
|
12:30 PM
1:10 PM
|
Greater Boston Expansion & Footprint
From Cambridge to Seaport, Somerville, Watertown, Waltham & beyond. |
|
1:10 PM
1:50 PM
|
Biotech Trends: Future of GMP Facilities
Determining how, when and where to create GMP facilities. |
|
1:50 PM
2:05 PM
|
Networking
|
|
2:05 PM
2:45 PM
|
Designing Facilities for Growth & Customization
Balancing your budget and customization of the space with the tenant's growth potential. |
|
2:45 PM
3:25 PM
|
Understanding the Tenant Experience: Difference between BioTech & Pharma
Understand the differing needs of biotech and pharma tenants and how developers and service providers can leverage that. |
|
3:25 PM
4:05 PM
|
Growth Opportunities for Boston's Newest Players
|
|
4:05 PM
4:15 PM
|
Post-Event Networking
Finish up the day with some more networking. |